Year: 2012
Type: dissertation
Abstract: Stem cells, despite being the subject of ethical and political debates, provide fascinating prospects for biomedical applications by both their ability to renew themselves and to differentiate into specialized cell types in vitro. Since the first isolation of murine embryonic stem cells in 1981, remarkable advances and groundbreaking findings were observed. During the past five years, the field gained further momentum by the discovery of a new platform technology (induced pluripotent stem cell (iPSC) technology) allowing the artificial creation of cells identical to embryonic stem cells from a donor’s adult somatic cells. The ability to readily obtain patient-specific stem cells and to differentiate them into a variety of embryonic tissue-specific progenitors and adult somatic cells has opened the door to the development of stem cell based models of human diseases. This cumulative thesis relies on the iPSC technology to investigate how patient-specific induced pluripotent stem cells can be used as an in vitro model system to study congenital and adult forms of genetic cardiac diseases, such as long-QT syndrome and catecholaminergic polymorphic ventricular tachycardia, and to investigate the potential of these cells for screening drug compounds and for developing patient-specific therapies.
Author: Christian Billy Jung
Institution: Technical University of Munich
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2752980167
